St. Baldrick’s Foundation shared a post on LinkedIn:
“New research published in the Journal of Clinical Oncology examines outcomes of hematopoietic stem cell transplantation in pediatric patients with high-risk acute myeloid leukemia.
The findings offer key insights into how transplant strategies impact survival and could help shape future treatment decisions for this aggressive form of cancer in children.”
Title: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group
Authors: Benjamin J. Huang, Lauren K. Meyer, Todd A. Alonzo, Yi-Cheng Wang, Adam J. Lamble, Rhonda E. Ries, Weijie Wang, Betsy Hirsch, Gordana Raca, Xiaotu Ma, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Todd M. Cooper, Katherine Tarlock, Michael R. Loken, Soheil Meshinchi, Joseph H. Chewning, William G. Woods, John T. Horan
You can read the Full Article on Journal of Clinical Oncology
More posts featuring St. Baldrick’s Foundation.